This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Abbott Laboratories Corporation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Roger L. Deaton and His Patent on Tiagabine for Pain Treatment.
Introduction
Roger L. Deaton is an inventor associated with Wadsworth, Illinois, United States. His recorded patent work concerns the use of tiagabine for treating pain associated with diabetic neuropathy and migraine.
Latest Patents
Deaton is credited with 1 patent: “Use of Tiagabine for Treatment of Diabetic Neuropathy and Migraine.” The patent describes (R)-N-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid and its salts as GABA uptake inhibitory compounds with pharmacological effects on pain associated with diabetic neuropathy and migraine.
Career Highlights
Deaton’s listed company affiliation is Abbott Laboratories Corporation. His patent reflects research into the potential therapeutic applications of compounds that inhibit GABA uptake.
Collaborations
Deaton’s listed coworkers include Stephen D. Collins and William J. Giardina.
Conclusion
Roger L. Deaton’s recorded invention connects GABA uptake inhibition with potential treatment approaches for pain associated with diabetic neuropathy and migraine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
